KR100786759B1 - Hccr-1을 포함하는 유방암 예후 마커 및 비만 유도조성물 - Google Patents
Hccr-1을 포함하는 유방암 예후 마커 및 비만 유도조성물 Download PDFInfo
- Publication number
- KR100786759B1 KR100786759B1 KR1020060064035A KR20060064035A KR100786759B1 KR 100786759 B1 KR100786759 B1 KR 100786759B1 KR 1020060064035 A KR1020060064035 A KR 1020060064035A KR 20060064035 A KR20060064035 A KR 20060064035A KR 100786759 B1 KR100786759 B1 KR 100786759B1
- Authority
- KR
- South Korea
- Prior art keywords
- hccr
- apoe
- cells
- breast cancer
- protein
- Prior art date
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
Abstract
Description
ER/PR 발현, p53 상태 및 HER2 활성을 포함하는 공지된 유방암 예후 인자와 HCCR-1 발현 레벨의 상관관계 | |||||
암 조직의 수 | ER 상태 | PR 상태 | p53 상태 | HER2 활성 | HCCR-1 발현 |
8 | + | + | 돌연변이 | 고 | 매우 강함 |
8 | + | + | 야생형 | 중 | 강함 |
5 | + | + | 야생형 | 저 | 약함 |
9 | - | - | 널(null) | 저 | 없음 |
Claims (7)
- 삭제
- 삭제
- 삭제
- HCCR-1 단백질을 포함하는 비만 유도용 조성물.
- HCCR-1 단백질로 형질전환된 비만 트랜스제닉 비-인간 포유동물.
- 제5항에 있어서, 상기 동물은 마우스, 래트, 토끼, 양, 소, 염소 및 돼지로 구성된 그룹 중에서 선택되는 비만 트랜스제닉 비-인간 포유동물.
- 제4항 또는 제5항에 있어서, 상기 HCCR-1 단백질의 서열은 서열번호 1에 기재된 것을 특징으로 하는 조성물.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060064035A KR100786759B1 (ko) | 2006-07-07 | 2006-07-07 | Hccr-1을 포함하는 유방암 예후 마커 및 비만 유도조성물 |
JP2009517999A JP2009543044A (ja) | 2006-07-07 | 2007-07-06 | Hccr−1を含む乳癌予後マーカー及び肥満誘導組成物 |
CNA2007800334744A CN101512345A (zh) | 2006-07-07 | 2007-07-06 | 包括hccr-1的乳腺癌预后标志物和诱导肥胖的组合物 |
PCT/KR2007/003293 WO2008004833A1 (en) | 2006-07-07 | 2007-07-06 | Prognostic marker for breast cancer and composition for inducing obesity comprising hccr-1 |
EP07793194A EP2044442A4 (en) | 2006-07-07 | 2007-07-06 | PROGNOSTIC MARKERS FOR BREAST CANCER AND COMPOSITION FOR INDUCTING FATIBLEITY WITH HCCR-1 |
US12/309,102 US20100205681A1 (en) | 2006-07-07 | 2007-07-06 | Prognostic marker for breast cancer and composition for inducing obesity comprising hccr-1 |
CA002656926A CA2656926A1 (en) | 2006-07-07 | 2007-07-06 | Prognostic marker for breast cancer and composition for inducing obesity comprising hccr-1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060064035A KR100786759B1 (ko) | 2006-07-07 | 2006-07-07 | Hccr-1을 포함하는 유방암 예후 마커 및 비만 유도조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100786759B1 true KR100786759B1 (ko) | 2007-12-18 |
Family
ID=38894757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060064035A KR100786759B1 (ko) | 2006-07-07 | 2006-07-07 | Hccr-1을 포함하는 유방암 예후 마커 및 비만 유도조성물 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100205681A1 (ko) |
EP (1) | EP2044442A4 (ko) |
JP (1) | JP2009543044A (ko) |
KR (1) | KR100786759B1 (ko) |
CN (1) | CN101512345A (ko) |
CA (1) | CA2656926A1 (ko) |
WO (1) | WO2008004833A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004022580A2 (en) | 2002-09-09 | 2004-03-18 | Dana-Farber Cancer Institute, Inc. | Bh3 peptides and method of use thereof |
US8221966B2 (en) | 2006-03-31 | 2012-07-17 | Dana Farber Cancer Institute | Methods of determining cellular chemosensitivity |
EP2826790B1 (en) | 2012-03-15 | 2019-02-13 | SNU R&DB Foundation | Anti-gremlin-1 antibody |
AU2013317985B2 (en) | 2012-09-19 | 2019-06-13 | Dana-Farber Cancer Institute, Inc. | Dynamic BH3 profiling |
CN105452865A (zh) * | 2013-08-06 | 2016-03-30 | 金弦起 | 小肝细胞癌和潜伏于肝硬化的肝细胞癌诊断用组合物 |
AU2014323526B2 (en) | 2013-09-19 | 2020-07-23 | Dana-Farber Cancer Institute, Inc. | Methods of BH3 profiling |
EP3288964B1 (en) | 2015-04-27 | 2024-02-21 | Dana-Farber Cancer Institute, Inc. | High throughput bh3 profiling: a rapid and scalable technology to bh3 profile on low numbers of cells |
CN107576798A (zh) * | 2017-08-30 | 2018-01-12 | 福建师范大学 | Vdac1蛋白在制备乳腺癌术后预后评估试剂盒中的应用、乳腺癌预后评估试剂盒及方法 |
KR102211972B1 (ko) * | 2018-08-02 | 2021-02-04 | 엑소젠 피티이. 엘티디 | 액체생검 다중 암 유전자 바이오마커를 이용한 유방암 조기진단 및 치료 후 모니터링 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3574900A (en) * | 1999-10-15 | 2001-04-23 | Jin Woo Kim | Human cervical cancer 1 protooncogene and protein encoded therein |
KR100426452B1 (ko) * | 2001-01-02 | 2004-04-13 | 김진우 | 인간 원암 유전자로 형질전환된 포유동물 및 이 유전자를이용한 유방암, 신장암, 난소암 또는 위암 진단용 키트 |
WO2006016110A1 (en) * | 2004-08-10 | 2006-02-16 | University College Cardiff Consultants Limited | Methods and kit for the prognosis of breast cancer |
WO2006036788A2 (en) * | 2004-09-22 | 2006-04-06 | Tripath Imaging, Inc. | Methods and compositions for evaluating breast cancer prognosis |
-
2006
- 2006-07-07 KR KR1020060064035A patent/KR100786759B1/ko active IP Right Grant
-
2007
- 2007-07-06 CA CA002656926A patent/CA2656926A1/en not_active Abandoned
- 2007-07-06 CN CNA2007800334744A patent/CN101512345A/zh active Pending
- 2007-07-06 WO PCT/KR2007/003293 patent/WO2008004833A1/en active Application Filing
- 2007-07-06 JP JP2009517999A patent/JP2009543044A/ja active Pending
- 2007-07-06 US US12/309,102 patent/US20100205681A1/en not_active Abandoned
- 2007-07-06 EP EP07793194A patent/EP2044442A4/en not_active Withdrawn
Non-Patent Citations (2)
Title |
---|
NCBI GenBank Accession No. AAK34885 (2005.06.02.) |
S.S.Jung et.al., Clin Cancer Res 2005;11(21) Nov.1, 2005 |
Also Published As
Publication number | Publication date |
---|---|
JP2009543044A (ja) | 2009-12-03 |
US20100205681A1 (en) | 2010-08-12 |
CN101512345A (zh) | 2009-08-19 |
CA2656926A1 (en) | 2008-01-10 |
WO2008004833A1 (en) | 2008-01-10 |
EP2044442A4 (en) | 2010-04-28 |
EP2044442A1 (en) | 2009-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100786759B1 (ko) | Hccr-1을 포함하는 유방암 예후 마커 및 비만 유도조성물 | |
Dunn et al. | A novel role of myosin VI in human prostate cancer | |
Lachat et al. | Expression of NDRG1, a differentiation-related gene, in human tissues | |
Fazili et al. | Disabled-2 inactivation is an early step in ovarian tumorigenicity | |
Cynthia A et al. | Overexpression of C/EBPβ-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer | |
US9316654B2 (en) | TAZ/WWTR1 for diagnosis and treatment of cancer | |
Wang et al. | p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-κB transcription factor p50 | |
US7767789B2 (en) | Truncated proteins as cancer markers | |
EP1062514B1 (en) | C-myc coding region determinant-binding protein (crd-bp) | |
Luu et al. | Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis | |
Discenza et al. | WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2 | |
Bravou et al. | Expression of the licensing factors, Cdt1 and Geminin, in human colon cancer | |
Qutob et al. | Microtubule-dependent subcellular redistribution of the transcriptional coactivator p/CIP | |
JP4718556B2 (ja) | 癌の診断と治療のためのaimp2dx2の用途 | |
US8853183B2 (en) | Prognosis and treatment of breast cancer | |
Varma et al. | Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain | |
Fukuda et al. | Distribution of Tsc1 protein detected by immunohistochemistry in various normal rat tissues and the renal carcinomas of Eker rat: detection of limited colocalization with Tsc1 and Tsc2 gene products in vivo | |
Wang et al. | Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-β1/SMAD3 Pathway In Vivo and In vitro | |
Zhai et al. | HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS | |
Saito et al. | Analysis of glial cell line–derived neurotrophic factor–inducible zinc finger protein 1 expression in human diseased kidney | |
Jakhotia et al. | Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes | |
July | c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
FPAY | Annual fee payment |
Payment date: 20130605 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131127 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141205 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160226 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170607 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171207 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20181211 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20191126 Year of fee payment: 13 |